CAI Q3 2018 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$115M+28.1% YoY

Gross Profit

$57M49.1% margin

Operating Income

$40M34.9% margin

Net Income

$22M18.8% margin

EPS (Diluted)

$1.12

QoQ Revenue Growth

+9.2%

Cash Flow

Operating Cash Flow

$61M

Free Cash Flow

-$196M

Stock-Based Comp.

$751,000

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$2.3B

Stockholders' Equity

$696M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$115M	$90M	+28.1%
Gross Profit	$57M	$45M	+27.2%
Operating Income	$40M	$30M	+33.2%
Net Income	$22M	$18M	+23.7%